Third Rock Ventures as of Sept. 30, 2015
Portfolio Holdings for Third Rock Ventures
Third Rock Ventures holds 5 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Global Blood Therapeutics In | 58.1 | $622M | 15M | 42.16 | |
| Sage Therapeutics (SAGE) | 25.5 | $273M | 6.4M | 42.32 | |
| Blueprint Medicines (BPMC) | 14.7 | $158M | 7.4M | 21.34 | |
| Eleven Biotherapeutics | 1.1 | $12M | 4.8M | 2.41 | |
| Zafgen | 0.6 | $6.7M | 210k | 31.95 |
